epigastralgia caused by acute cholecystitis 3 days after percutaneous coronary intervention to treat acute coronary syndrome. As he was at risk of requiring anticoagulation therapy, percutaneous transhepatic gallbladder drainage was performed on the same day, and a choledocholithiasis was detected via cholangiography (▶ Fig. 3 ). Then, 3 months later, after his heart condition had stabilized, we performed endoscopic choledocholithiasis extraction and endoscopic transpapillary gallbladder stenting (ETGS) to remove the percutaneous catheter and prevent future acute cholecystitis. Case 2: a 65-year-old man was admitted with epigastralgia caused by recurrent acute cholecystitis; he was awaiting preventative cholecystectomy (▶ Fig. 4) . A new choledocholithiasis originating from the gallbladder was detected on computed tomography; we extracted it and then performed subsequent ETGS as a bridge to cholecystectomy. In both cases, tortuous cystic ducts hindered the advancement of a regular guidewire, with "popping up" of its flexible tip portion (▶ Fig. 1 ). Therefore, we used the improved M-through guidewire (ASAHI INTECC Corp., Seto, Japan), which was maneuvered easily and was successfully passed through both cystic ducts; we placed plastic stents along the guidewires. The new guidewire has an innovative tip allowing smooth tracking and easy maneuverability. This guidewire was passed rapidly through tortuous cystic ducts, followed by plastic stent placement in the gallbladder (▶ Fig. 5) . ▶ Fig. 5 A fluoroscopic image obtained after performing endoscopic transpapillary gallbladder stenting in Case 1. A 5 Fr × 13 cm single-pigtail stent (Gadelius Medical K. K., Sagamihara, Japan) was finally placed along the guidewire into the gallbladder.
